Zhu Xiaoming

Dr. Zhu Xiaoming


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2024 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
QCQiaoli Cui
Qiaoli Cui
ZZZhenming Zhang
Zhenming Zhang
LQLang Qin
Lang Qin
ZTZhaolin Teng
Zhaolin Teng
ZWZhihong Wang
Zhihong Wang
ZXZhu Xiaoming
Zhu Xiaoming
Aims/Introduction: Diabetic foot ulcer (DFU) is a prevalent complication of diabetes characterized by heightened inflammation and impaired wound‐healing processes. Interleukin‐37 (IL‐37) is a natural suppressor of innate inflammation. Here, we aim to investigate the potential of IL‐37 in enhancing the healing process of diabetic wounds.Materials and Methods: The skin samples of DFU and non‐diabetic patients during foot and ankle orthopedic surgery were collected. The IL‐37 transgenic mice (IL‐37Tg) were created using CRISPR/Cas‐mediated genome engineering. Mice were administered streptozotocin (STZ, 150 mg/kg) to induce a diabetic model. After 4 weeks, an equidistant full‐thickness excisional wound measuring 8 mm was created on the central back of each mouse and allowed to heal naturally. Body weight and blood glucose levels were measured weekly. The wound area was measured, and skin samples were collected on Day 10 for further Quantitative polymerase chain reaction (qPCR) and WB detection and RNA sequencing analysis.Results: The proinflammation cytokines such as TNF‐α and IL‐1β and the MAPK signaling pathway were significantly increased in the wound margin of DFU patients. Compared with diabetic mice, diabetic IL‐37Tg mice showed a significantly accelerated healing process. The enriched signaling pathways in RNA sequencing included cytokine–cytokine receptor interaction, TNF signaling pathway, and NOD‐like receptor signaling pathway. Through QPCR and WB detection, we found that IL‐37 could inhibit the activated MAPK and NOD‐like signaling pathway, reducing TNF‐α, IL‐1β, and NLRP3 expression in the diabetic wound.Conclusions: IL‐37 promotes skin wound healing in diabetic mice, providing a new possible target for treating diabetic wounds.

7 November 2026 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
YHYexuan Hao
Yexuan Hao
QCQiaoli Cui
Qiaoli Cui
LQLang Qin
Lang Qin
WSWanwan Sun
Wanwan Sun
SZShiwei Zhou
Shiwei Zhou
ZXZhu Xiaoming
Zhu Xiaoming
Objective: To investigate the association between serum calcium levels and cold perception threshold (CPT) in patients with type 2 diabetes mellitus. Methods: This retrospective study analyzed 334 type 2 diabetes mellitus patients from a tertiary hospital endocrinology department (March 2020–November 2024). Clinical, laboratory, and quantitative sensory testing (QST) data were collected. The correlations between serum calcium and cold/heat perception thresholds (CPT/HPT) were assessed using correlation analysis, multiple linear regression, and multivariable fractional polynomial (MFP) modeling. Results: Among the 334 enrolled patients with type 2 diabetes mellitus (146 DM only; 188 with DPN), the DPN group was older and had longer diabetes duration (both P < 0.001). Patients with DPN demonstrated significantly impaired thermal sensation, with lower CPT and higher HPT than the DM group (both P < 0.001). Serum calcium positively correlated with mean CPT in both the total cohort ( r = 0.170, P = 0.001) and the DPN subgroup ( r = 0.160, P = 0.028), and negatively correlated with mean HPT in the total cohort ( r = −0.115, P = 0.031) and the DPN subgroup ( r = −0.175, P = 0.017), but not in the DM‐only group. A calcium‐CPT dose–response relationship was observed. Conclusion: Serum calcium is an independent influencing factor for CPT in patients with type 2 diabetes mellitus, with a dose–response relationship observed. This finding suggested that in type 2 diabetes mellitus patients with low serum calcium levels, there should be heightened awareness of the risks of impaired cold perception and aggravated neuropathy, thereby enabling earlier risk stratification and personalized management.